Inhibrx Biosciences, Inc. Quarterly Assets in USD from Q4 2023 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Inhibrx Biosciences, Inc. quarterly Assets history and growth rate from Q4 2023 to Q2 2025.
Inhibrx Biosciences, Inc. Assets for the quarter ending June 30, 2025 was $212M, a 17.9% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$212M	-$46.3M	-17.9%	Jun 30, 2025	10-Q	2025-08-13
Q1 2025	$243M			Mar 31, 2025	10-Q	2025-05-14
Q4 2024	$181M	-$127M	-41.3%	Dec 31, 2024	10-Q	2025-08-13
Q3 2024	$223M			Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$258M			Jun 30, 2024	10-Q	2024-08-13
Q4 2023	$308M			Dec 31, 2023	10-K	2025-03-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.